CD1-reactive leukemic cells in bone marrow: presence of Langerhans cell marker on leukemic monocytic cells.
Langerhans cells originate in bone marrow and probably belong to the monocyte-macrophage lineage. CD1 is a specific marker of Langerhans cells. By immunofluorescence and immunoelectron microscopy, CD1a antigen and myeloid markers (CD11, CD13, CD14, CD15, CD33, HLA-DR) were studied in 53 cases of acute myeloid leukemias (AML) and 3 acute lymphoblastic leukemias (ALL). The 11 ANLL without monocytic component were CD1a negative. 2/5 of acute myelomonocytic leukemias (AML4) and 9/37 of acute monocytic leukemias (AML5) were positive. All 3 ALL were negative. No correlation was found between CD1a and myeloid markers. CD1a+ AML did not differ from CD1a- AML with regard to cytogenetics or response to therapy. The CD1a positive cells may originate from an abnormal proliferation of CD1a positive cells which are present in bone marrow and which may differentiate into Langerhans cell precursors.
Laboratoire de Recherche Dermatologique et Immunologie, Unité Inserm 209, Hopital Edouard Herriot, France.
L
L
Misery
L
L
Campos
C
C
Dezutter-Dambuyant
D
D
Guyotat
D
D
Treille
D
D
Schmitt
J
J
Thivolet
D015703:Antigens, CD / Q000032:analysis*; D018949:Antigens, CD1; D000954:Antigens, Surface / Q000032:analysis; D015415:Biomarkers; D001853:Bone Marrow / Q000276:immunology / Q000473:pathology*; D005455:Fluorescent Antibody Technique; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D007621:Karyotyping; D007801:Langerhans Cells / Q000276:immunology / Q000473:pathology*; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D008854:Microscopy, Electron; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology / Q000473:pathology / Q000648:ultrastructure; D011379:Prognosis
D015703:Antigens, CD; D018949:Antigens, CD1; D000954:Antigens, Surface; D015415:Biomarkers; D006684:HLA-DR Antigens